Most studies highlight the effectiveness of combined therapies, particularly those incorporating metformin and GLP-1 receptor agonists, like liraglutide and exenatide, for the management of both metabolic and reproductive issues linked to PCOS. Here, GLP1R is linked to polycystic ovary syndrome.